Advanced Raman Spectroscopy for Exhaled Breath Analysis for Lung Cancer Detection

用于肺癌检测的呼出气体分析的先进拉曼光谱

• 批准号: 494958
• 负责人: Zeng Haishan
• 金额: $ 7.29万
• 依托单位: B.C. Cancer Research Centre (Vancouver)
• 依托单位国家: 加拿大
• 项目类别: Operating Grants
• 财政年份: 2023
• 资助国家: 加拿大
• 起止时间: 2023-09-01 至 2024-09-01
• 项目状态: 已结题
• 来源: https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=494958&lang=en
• 关键词: Biomarkers; Biophotonics; Breath Analysis; Lung Cancer; Lung Cancer Screening; Non-Invasive Diagnosis; Optical Diagnosis; Raman Spectroscopy; Stimulated Raman Scattering; Volatile Organic Compounds (Vocs); Biomarkers; Biophotonics; Breath Analysis; Lung Cancer; Lung Cancer Screening; Non-Invasive Diagnosis; Optical Diagnosis; Raman Spectroscopy; Stimulated Raman Scattering; Volatile Organic Compounds (Vocs)

Despite many medical advances, the survival rate for lung cancer (LC) in Canada is still very low: 19% (males) and 26% (females), with an estimated 20,700 Canadians dying of the disease in 2022. These grim statistics should be compared with those fortuna

尽管有许多医疗进展，但加拿大肺癌（LC）的存活率仍然很低：19％（男性）和26％（女性），估计有20,700名加拿大人在2022年死亡。